NEKTAR THERAPEUTICS Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 7.21 | 37,500 | 270,375 | 0 | |
| Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 11.34 | 75,000 | 850,500 | 0 | |
| Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 19.69 | 112,500 | 2,215,125 | 55,637 | 168.1 K to 55.6 K (-66.91 %) |
| Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 7.21 | 37,500 | 270,375 | 168,137 | 130.6 K to 168.1 K (+28.71 %) |
| Mar 22 2017 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 11.34 | 75,000 | 850,500 | 130,637 | 55.6 K to 130.6 K (+134.80 %) |
| Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.37 | 14,000 | 117,180 | 0 | |
| Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.37 | 14,000 | 117,180 | 98,000 | 84 K to 98 K (+16.67 %) |
| Mar 16 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 8.37 | 5,000 | 41,850 | 10,000 | |
| Mar 16 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 15.41 | 5,000 | 77,050 | 271,623 | 276.6 K to 271.6 K (-1.81 %) |
| Mar 16 2017 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 8.37 | 5,000 | 41,850 | 276,623 | 271.6 K to 276.6 K (+1.84 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 9.24 | 25,000 | 231,000 | 0 | |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 6.34 | 7,494 | 47,512 | 0 | |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 6.34 | 167,506 | 1,061,988 | 7,494 | |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.21 | 25,000 | 380,250 | 69,270 | 94.3 K to 69.3 K (-26.52 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 9.24 | 25,000 | 231,000 | 94,270 | 69.3 K to 94.3 K (+36.09 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.21 | 7,494 | 113,984 | 69,270 | 76.8 K to 69.3 K (-9.76 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 6.34 | 7,494 | 47,512 | 76,764 | 69.3 K to 76.8 K (+10.82 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.15 | 167,506 | 2,537,716 | 69,270 | 236.8 K to 69.3 K (-70.74 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 6.34 | 167,506 | 1,061,988 | 236,776 | 69.3 K to 236.8 K (+241.82 %) |